Tyra Biosciences, Inc.
TYRA
$20.92
$0.110.53%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 4.65% | 3.73% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.74% | -1.25% | |||
| Operating Income | -4.74% | 1.25% | |||
| Income Before Tax | -6.30% | 0.17% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -6.30% | 0.17% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -6.30% | 0.17% | |||
| EBIT | -4.74% | 1.25% | |||
| EBITDA | -4.79% | 1.25% | |||
| EPS Basic | -6.08% | 0.55% | |||
| Normalized Basic EPS | -6.07% | 0.54% | |||
| EPS Diluted | -6.08% | 0.55% | |||
| Normalized Diluted EPS | -6.07% | 0.54% | |||
| Average Basic Shares Outstanding | 0.20% | 0.36% | |||
| Average Diluted Shares Outstanding | 0.20% | 0.36% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||